Dispelling Misconceptions About OSHA 1910.22 in Pharmaceutical Manufacturing

In the pharmaceutical industry, safety is not just a priority—it's a necessity. Yet, there's often confusion surrounding the application of OSHA 1910.22, which covers aisles, stairways, walkways, and crawlways. Let's dive into some common misconceptions and clarify the facts to keep your operations both compliant and safe.

Misconception 1: OSHA 1910.22 Only Applies to General Industry

Some believe that OSHA 1910.22 regulations are strictly for general industry and not applicable to pharmaceutical manufacturing. This is incorrect. The pharmaceutical sector falls under general industry, meaning that these regulations are indeed relevant. I've seen cases where pharmaceutical companies thought they were exempt, only to face penalties during inspections.

Misconception 2: Aisles and Walkways Need Only Be Marked

It's a common misunderstanding that simply marking aisles and walkways is sufficient under OSHA 1910.22. In reality, these areas must be kept clear of obstructions at all times. From my experience, cluttered walkways in pharmaceutical plants can lead to serious accidents. Not only do they need to be marked, but they also require regular maintenance to ensure they remain safe passages.

Misconception 3: Stairways Are Safe Without Handrails

There's a myth that stairways in pharmaceutical facilities don't need handrails if they're not excessively steep. According to OSHA, any stairway with four or more risers must have at least one handrail. We've encountered situations where pharmaceutical companies overlooked this, resulting in unnecessary risks to employee safety.

Misconception 4: Crawlways Are Not a Concern

Many think that crawlways in pharmaceutical manufacturing don't warrant the same attention as other pathways. However, OSHA 1910.22 mandates that all pathways, including crawlways, must be free from hazards. I've seen firsthand how neglecting crawlway safety can lead to injuries, particularly in areas where maintenance is frequently required.

Misconception 5: Compliance Is a One-Time Effort

Another misconception is that once a facility is compliant with OSHA 1910.22, no further action is needed. Compliance is an ongoing process. Regular assessments and updates are essential to maintain safety standards. In my years of consulting, I've found that continuous improvement in safety protocols is what keeps pharmaceutical operations both safe and compliant.

Understanding and applying OSHA 1910.22 correctly is crucial for safety in pharmaceutical manufacturing. By dispelling these misconceptions, we can foster a safer working environment. For those looking to delve deeper, the OSHA website provides detailed guidelines on these regulations.